| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $17.7M | -9.0% |
| SG&A Expense | $8.8M | -12.3% |
| Operating Income | -$26.6M | +10.1% |
| Income Tax | $0 | — |
| Net Income | -$21.8M | +26.9% |
| EPS (Basic) | -$6.32 | +58.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.3M | -81.8% |
| Current Assets | $5.2M | -80.2% |
| Total Assets | $16.9M | -55.7% |
| Current Liabilities | $5.4M | -21.4% |
| Total Liabilities | $10.9M | -9.9% |
| Stockholders' Equity | $6.0M | -77.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.9M | +1.0% |
| Capital Expenditures | $13K | -89.5% |
| Investing Cash Flow | -$13K | +89.5% |
| Financing Cash Flow | $4.6M | -0.3% |
| Free Cash Flow | -$23.9M | +1.4% |